Epithelial ovarian cancer
Epithelial ovarian cancer generally presents at an advanced stage and is the most common
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …
Ovarian cancer
GC Jayson, EC Kohn, HC Kitchener, JA Ledermann - The Lancet, 2014 - thelancet.com
Epithelial ovarian cancer is the commonest cause of gynaecological cancer-associated
death. The disease typically presents in postmenopausal women, with a few months of …
death. The disease typically presents in postmenopausal women, with a few months of …
Epithelial ovarian carcinoma
GB Kristensen, C Tropé - The Lancet, 1997 - thelancet.com
Introduction Ovarian cancer is the second most common gynaecological cancer and is the
leading cause of death from gynaecological cancers, except breast cancer, with an …
leading cause of death from gynaecological cancers, except breast cancer, with an …
Ovarian cancer
BT Hennessy, RL Coleman, M Markman - The lancet, 2009 - thelancet.com
The standard initial management of epithelial ovarian cancer consists of surgical staging,
operative tumour debulking including total abdominal hysterectomy and bilateral salpingo …
operative tumour debulking including total abdominal hysterectomy and bilateral salpingo …
Treatment of epithelial ovarian cancer
L Kuroki, SR Guntupalli - Bmj, 2020 - bmj.com
Ovarian cancer is the third most common gynecologic malignancy worldwide but accounts
for the highest mortality rate among these cancers. A stepwise approach to assessment …
for the highest mortality rate among these cancers. A stepwise approach to assessment …
Part II: Chemotherapy for epithelial ovarian cancer-treatment of rcurrent disease
M Harries, M Gore - The lancet oncology, 2002 - thelancet.com
For women with advanced ovarian cancer, rates of response to first-line chemotherapy are
high but most patients have relapses and become candidates for further chemotherapy …
high but most patients have relapses and become candidates for further chemotherapy …
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
I Vergote, A Gonzalez-Martin, D Lorusso… - The Lancet …, 2022 - thelancet.com
Summary The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on
Clinical Research was held virtually in October, 2021, following published consensus …
Clinical Research was held virtually in October, 2021, following published consensus …
Epithelial ovarian cancer: evolution of management in the era of precision medicine
S Lheureux, M Braunstein… - CA: a cancer journal for …, 2019 - Wiley Online Library
Ovarian cancer is the second most common cause of gynecologic cancer death in women
around the world. The outcomes are complicated, because the disease is often diagnosed …
around the world. The outcomes are complicated, because the disease is often diagnosed …
Part I: Chemotherapy for epithelial ovarian cancer–treatment at first diagnosis
M Harries, M Gore - The lancet oncology, 2002 - thelancet.com
Ovarian cancer leads to more deaths than any other gynaecological cancer in the more
developed countries. During the past 30 years, survival has increased owing to …
developed countries. During the past 30 years, survival has increased owing to …
Early versus delayed treatment of relapsed ovarian cancer
G Rustin, M Van Der Burg, C Griffin, W Qian, AM Swart - The Lancet, 2011 - thelancet.com
Specific regimens were not mandated in the protocol, but sites used best practice at the time.
Clinicians chose the most effective treatment available for their patients. Contrary to Morris …
Clinicians chose the most effective treatment available for their patients. Contrary to Morris …